MedPath

Observational Study of Sinus Rhythm Mapping in Pulmonary Vein Isolation Naive Patients With Atrial Fibrillation

Recruiting
Conditions
Atrial Fibrillation
Registration Number
NCT06098664
Lead Sponsor
Ziekenhuis Oost-Limburg
Brief Summary

Atrial fibrillation (AF) initially starts in a paroxysmal form, which is mainly based on the presence of triggers. Progression of AF is accompanied by structural and electrical remodelling which can typically be described as a progressive change in electrophysiological properties of the myocardium caused by cardiovascular comorbidities and AF itself. This results in complex electrical conduction disorders, which is defined as electropathology. The aim of our study is to evaluate whether an artificial intelligence (AI)-enabled ECG algorithm (on an ECG in Sinus Rhythm) can predict electropathology in patients with AF who undergo a first PVI.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Provide signed and dated informed consent.
  • First PVI-procedure
  • Age is 18 years or higher.
  • 12-lead ECG available in SR during the last 14 days.
Exclusion Criteria
  • Mitral insufficiency of grade 3 or 4.
  • Participating in another study that may interfere with participation in this study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Low voltage areaDuring atrial voltage mapping, prior to PVI procedure.

Proportion of low voltage area in the left atrium. (Defined as a threshold 0.5mV)

Secondary Outcome Measures
NameTimeMethod
Conduction delay scoreDuring atrial voltage mapping, prior to PVI procedure.

Weighted score for conduction deceleration zones (taking in account the number of affected zones and the severity of conduction delay)

Conduction delayDuring atrial voltage mapping, prior to PVI procedure.

Number of deceleration zones in the left atrium. (Deceleration zone defined as a zone with a conduction speed of \<27cm/s)

Left atrial sizePrior to PVI procedure.

Measured on CT or MRI imaging

Transition zone voltage areaDuring atrial voltage mapping, prior to PVI procedure.

Proportion of transition zone voltage area in the left atrium. (Defined as a threshold 1mV)

Total LA conduction timeDuring atrial voltage mapping, prior to PVI procedure.

Based on LAT sampling

Left atrial appendage ejection velocity.Immediately prior to PVI procedure.

Measured with TEE pulsed wave doppler.

Conduction time from sinus node to Bachman bundleDuring atrial voltage mapping, prior to PVI procedure.

Based on Local Activation Time (LAT) sampling. Defined as first point in right atrium to first point in left atrium.

Pericardial adipose tissue volumePrior to PVI procedure.

Measured on CT or MRI imaging

Trial Locations

Locations (1)

Ziekenhuis Oost-Limburg

🇧🇪

Genk, Limburg, Belgium

Ziekenhuis Oost-Limburg
🇧🇪Genk, Limburg, Belgium
Henri Gruwez, MD
Contact
+3289212051
henri.gruwez@zol.be
CTU Clinical Trial Unit
Contact
+3289212021
CTU@zol.be

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.